[go: up one dir, main page]

UY24270A1 - Nuevos peptidos derivados de la proteína 60 humana por choque térmico para el tratamiento de diabetes, las composiciones, los métodos y equipos. - Google Patents

Nuevos peptidos derivados de la proteína 60 humana por choque térmico para el tratamiento de diabetes, las composiciones, los métodos y equipos.

Info

Publication number
UY24270A1
UY24270A1 UY24270A UY24270A UY24270A1 UY 24270 A1 UY24270 A1 UY 24270A1 UY 24270 A UY24270 A UY 24270A UY 24270 A UY24270 A UY 24270A UY 24270 A1 UY24270 A1 UY 24270A1
Authority
UY
Uruguay
Prior art keywords
diabetes
compositions
treatment
equipment
methods
Prior art date
Application number
UY24270A
Other languages
English (en)
Inventor
Irun Cohen
Dana Elias
Rivka Abulafia
Jana Bockova
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of UY24270A1 publication Critical patent/UY24270A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

(i)Un anfígeno seleccionado de los pépticos de la invención; y (ii) un cuerpo marcado capaz de reconocer la región no variable de dichos anticuerpos anti-hsp60 a ser detectados. Un equipo para diagnosticar la presencia de DMID analizando la presencia de una célula T que inmunoreacciona con hsp60, comprenderá: (I). Para la prueba in vivo, el equipo comprenderá sólo un péptido de la invención en una forma adecuada para la inyección.
UY24270A 1995-06-30 1996-06-28 Nuevos peptidos derivados de la proteína 60 humana por choque térmico para el tratamiento de diabetes, las composiciones, los métodos y equipos. UY24270A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL11440795A IL114407A0 (en) 1995-06-30 1995-06-30 Novel peptides and pharmaceutical compositions comprising them

Publications (1)

Publication Number Publication Date
UY24270A1 true UY24270A1 (es) 2000-12-29

Family

ID=11067704

Family Applications (1)

Application Number Title Priority Date Filing Date
UY24270A UY24270A1 (es) 1995-06-30 1996-06-28 Nuevos peptidos derivados de la proteína 60 humana por choque térmico para el tratamiento de diabetes, las composiciones, los métodos y equipos.

Country Status (19)

Country Link
US (1) US6682897B1 (es)
EP (1) EP0845943B1 (es)
KR (1) KR100454554B1 (es)
CN (1) CN1102598C (es)
AR (1) AR003446A1 (es)
AT (1) ATE290315T1 (es)
AU (1) AU710882B2 (es)
CA (1) CA2225675C (es)
CZ (1) CZ295110B6 (es)
DE (1) DE69634438T2 (es)
DK (1) DK0845943T3 (es)
ES (1) ES2239770T3 (es)
HR (1) HRP960307A2 (es)
HU (1) HUP9901688A3 (es)
IL (2) IL114407A0 (es)
NO (1) NO320715B1 (es)
UY (1) UY24270A1 (es)
WO (1) WO1997001959A1 (es)
ZA (1) ZA965565B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6488933B2 (en) 1995-07-05 2002-12-03 Yeda Research And Development Co. Ltd. Preparations for the treatment of T cell mediated diseases
WO1997043649A1 (en) * 1996-05-14 1997-11-20 Winnacker Ernst Ludwig CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrP?sc¿
US5993803A (en) * 1996-08-30 1999-11-30 Yeda Research And Development Co., Ltd. Method of reducing the severity of host vs graft reaction by down-regulating hsp60 autoimmunity
EP1237570A4 (en) * 1999-12-15 2005-01-05 Peptor Ltd FRAGMENTS AND ANTAGONISTS OF THERMAL SHOCK PROTEINS 60
EP1335741A4 (en) * 2000-08-25 2005-10-26 Yeda Res & Dev METHOD FOR THE PREVENTION OF AUTOIMMUNE DISEASES WITH CpG-CONTAINING POLYNUCLEOTIDES (04.03.02)
WO2003063759A2 (en) 2002-01-31 2003-08-07 Peptor Ltd. Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
WO2003070761A1 (en) * 2002-02-19 2003-08-28 Yeda Research And Development Co. Ltd. Dual-effect ligands comprising anti-inflammatory hsp peptide epitopes for immunomodulation
ES2433915T3 (es) 2002-05-21 2013-12-13 Irun R. Cohen Vacunas de ADN que codifican proteínas de choque térmico
WO2004098489A2 (en) * 2003-05-12 2004-11-18 Peptor Ltd. Compositions and methods for modulation of specific epitopes of hsp60
WO2005048914A2 (en) * 2003-11-24 2005-06-02 Yeda Research & Development Co. Ltd. Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases
EP1718158B1 (en) 2004-01-28 2014-07-02 Andromeda Bio Tech Ltd. Hsp therapy in conjunction with a low antigenicity diet
US8691772B2 (en) 2005-01-04 2014-04-08 Yeda Research And Development Co. Ltd. HSP60, HSP60 peptides and T cell vaccines for immunomodulation
CU23701A1 (es) * 2008-12-29 2011-09-21 Ct Ingenieria Genetica Biotech Método de tratamiento de enfermedades inflamatorias intestinales y diabetes tipo i
KR101307132B1 (ko) * 2010-02-04 2013-09-10 이화여자대학교 산학협력단 비정상적 세포 증식 억제용 약제학적 조성물
ITCO20120007A1 (it) 2012-02-21 2013-08-22 Nuovo Pignone Srl Dispositivo di filtraggio dell'aria in ingresso per un impianto
WO2013128450A1 (en) 2012-03-01 2013-09-06 Yeda Research And Development Co. Ltd. Hsp60 derived peptides and peptide analogs for suppression and treatment of non-autoimmune diabetes
WO2013128453A1 (en) 2012-03-01 2013-09-06 Yeda Research And Development Co. Ltd. Regeneration of islet beta cells by hsp60 derived peptides
EP3448415A4 (en) * 2016-04-29 2019-11-06 Araim Pharmaceuticals, Inc. TREATMENT-PROOFING PEPTIDES FOR THE PREVENTION AND TREATMENT OF DISEASES AND DISORDERS RELATED TO TISSUE DAMAGE
CN111035755B (zh) * 2020-01-08 2023-04-14 中国医学科学院医学生物学研究所 一种1型糖尿病疫苗及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242823A (en) * 1986-03-07 1993-09-07 International Genetic Engineering, Inc. Cloning of the 38kd Mycoplasma hyorhinis regression-associated antigen
US4976958A (en) * 1987-02-26 1990-12-11 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides
US5114844A (en) * 1989-03-14 1992-05-19 Yeda Research And Development Co., Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus

Also Published As

Publication number Publication date
JP3955627B2 (ja) 2007-08-08
AU6484596A (en) 1997-02-05
EP0845943A1 (en) 1998-06-10
AR003446A1 (es) 1998-08-05
CA2225675A1 (en) 1997-01-23
DE69634438T2 (de) 2006-02-09
ES2239770T3 (es) 2005-10-01
IL122757A0 (en) 1998-08-16
CN1193889A (zh) 1998-09-23
IL122757A (en) 2001-07-24
NO976094D0 (no) 1997-12-29
IL114407A0 (en) 1995-10-31
EP0845943A4 (en) 2002-04-10
CZ411797A3 (cs) 1998-06-17
KR100454554B1 (ko) 2005-04-06
JPH11509196A (ja) 1999-08-17
CA2225675C (en) 2010-09-21
WO1997001959A1 (en) 1997-01-23
EP0845943B1 (en) 2005-03-09
HUP9901688A2 (hu) 1999-09-28
CZ295110B6 (cs) 2005-05-18
AU710882B2 (en) 1999-09-30
ZA965565B (en) 1997-02-26
ATE290315T1 (de) 2005-03-15
NO976094L (no) 1998-02-02
HRP960307A2 (en) 1998-04-30
MX9800191A (es) 1998-05-31
DK0845943T3 (da) 2005-07-11
DE69634438D1 (de) 2005-04-14
US6682897B1 (en) 2004-01-27
CN1102598C (zh) 2003-03-05
KR19990028640A (ko) 1999-04-15
NO320715B1 (no) 2006-01-23
HUP9901688A3 (en) 1999-12-28

Similar Documents

Publication Publication Date Title
UY24270A1 (es) Nuevos peptidos derivados de la proteína 60 humana por choque térmico para el tratamiento de diabetes, las composiciones, los métodos y equipos.
AR119235A1 (es) PROTEÍNAS DE FUSIÓN FLT3L-Fc Y MÉTODOS DE USO
Linke et al. Morphologic, chemical, and immunologic studies of amyloid-like fibrils formed from Bence Jones proteins by proteolysis
Hoffman Allergens in bee venom: III. Identification of allergen B of bee venom as an acid phosphatase
Eriksen et al. Mouse amyloid protein AA: Homology with nonimmunoglobulin protein of human and monkey amyloid substance.
NO331148B1 (no) Anvendelse av et monoklonalt eller polyklonalt antistoff, samt fremgangsmate og kit for in vitro diagnose.
ATE319091T1 (de) Diagnose von einheimischer sprue/zöliakie mit hilfe von gliadinepitopen
AR039231A1 (es) Agentes de union ox40r novedosos
NO985468D0 (no) Antistoff og diagnostisk preparat omfattende dette
DE69130506D1 (de) Nukleotidsequenzen kodierend für ein humanes protein mit angiogenetisch-regulatorischen eigenschaften
Unsworth et al. Studies on reticulin. I: Serological and immunohistological investigations of the occurrence of collagen type III, fibronectin and the non-collagenous glycoprotein of Pras and Glynn in reticulin
NZ512083A (en) Methods of increasing lean tissue mass using OB protein compositions
NO20000934D0 (no) Adipocyttspesifikke proteinhomologer
ES2123973T3 (es) Afamina: una proteina similar a la seroalbumina humana.
DK0532587T3 (da) Fremgangsmåder til trans-destabilisering af specifikke proteiner in vivo
DE69821246D1 (de) Testverfahren für collagenpeptid
ES2172287T4 (es) Metodos de deteccion y tratamiento de individuos con celulas anormales que expresan los antigenos peptidicos hla-a2/tirosinasa.
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
Franklin et al. The partial amino acid sequence of the major low molecular weight component of two human amyloid fibrils
DE69637130D1 (de) Immunoreaktive und immunotherapeutische moleküle welche in individuen mit insulin-abhängiger diabetes mellitus interagieren
NO963487L (no) Isolerte, tyrosinaseavledete peptider, samt anvendelser derav
FI913714A0 (fi) Peptider med foer a 1-mikroglobulin karakteristiska antigeniska determinanter.
KR910003095A (ko) 사람의 단백질 c변이체 및 이의 제조방법
IT1271486B (it) Oligopeptidi immunomodulatori derivati di frammenti della proteina c- reattiva
ATE414279T1 (de) Test für zelluläre immunität mittels an einen festen träger gebundener peptide

Legal Events

Date Code Title Description
ABAN Application deemed to be withdrawn (no publication fee paid)

Effective date: 20050125